Catherine Saï-Maurel
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 20
- Monoclonal and Polyclonal Antibodies Research 10
- Medical Imaging Techniques and Applications 4
- Radiomics and Machine Learning in Medical Imaging 2
- Oncology 5
- Peptidase Inhibition and Analysis 4
- Co-authors
- Alain Faivre-Chauvet (15 shared papers)Jacques Barbet (13 shared papers)Françoise Kraeber‐Bodéré (10 shared papers)Philippe Thédrez (12 shared papers)Michel Chérel (9 shared papers)Jean‐François Gestin (8 shared papers)Emmanuel Gautherot (5 shared papers)Mickaël Bourgeois (3 shared papers)
- Journals
- Nuclear Medicine and Biology (3 papers)Bioconjugate Chemistry (2 papers)Journal of Nuclear Medicine (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Oncotarget (1 paper)
- Partner nations
- FranceUnited StatesTunisia
In The Last Decade
Catherine Saï-Maurel
24 papers receiving 419 citations
Peers
Comparison fields: 5 of 47
- Radiology, Nuclear Medicine and Imaging 303
- Oncology 106
- Hematology 25
- Pathology and Forensic Medicine 29
- Biomaterials 22
Countries citing papers authored by Catherine Saï-Maurel
This map shows the geographic impact of Catherine Saï-Maurel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Saï-Maurel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Saï-Maurel more than expected).
Fields of papers citing papers by Catherine Saï-Maurel
This network shows the impact of papers produced by Catherine Saï-Maurel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Saï-Maurel. The network helps show where Catherine Saï-Maurel may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Saï-Maurel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 58 | |
| 2 | Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies. | 2001 | 42 |
| 3 | 2011 | 35 | |
| 4 | Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft. | 1999 | 31 |
| 5 | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. | 2002 | 30 |
| 6 | 2007 | 27 | |
| 7 | Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. | 1999 | 25 |
| 8 | Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma. | 1999 | 25 |
| 9 | 2019 | 24 | |
| 10 | 2017 | 19 | |
| 11 | 2010 | 18 | |
| 12 | 2005 | 17 | |
| 13 | 2018 | 14 | |
| 14 | 1993 | 13 | |
| 15 | 1996 | 13 | |
| 16 | 1993 | 9 | |
| 17 | 1992 | 8 | |
| 18 | Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. | 1999 | 7 |
| 19 | 1993 | 4 | |
| 20 | A new tumor-associated antigen expressed on breast carcinomas, defined by monoclonal antibody BCA 227. | 1991 | 4 |
About Catherine Saï-Maurel
Catherine Saï-Maurel is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 24 papers that have together received 429 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Peptidase Inhibition and Analysis (4 papers), Medical Imaging Techniques and Applications (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Glycosylation and Glycoproteins Research (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (303 citations), Oncology (106 citations), Hematology (25 citations), Pathology and Forensic Medicine (29 citations) and Biomaterials (22 citations). Catherine Saï-Maurel has collaborated with scholars based in France, United States and Tunisia. Frequent co-authors include Alain Faivre-Chauvet, Jacques Barbet, Françoise Kraeber‐Bodéré, Philippe Thédrez, Michel Chérel, Jean‐François Gestin, Emmanuel Gautherot, Mickaël Bourgeois, Sébastien Gouard and L. Campion. Their work appears in journals such as Nuclear Medicine and Biology, Bioconjugate Chemistry, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.